Zolpidem Tartrate 51991-0981-01
- Manufacturer
- Breckenridge Pharmaceutical, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIV
- Marketing Start
- May 18, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA213592
Active Ingredients
| Ingredient | Strength |
|---|---|
| Zolpidem Tartrate | 6.25 mg/1 |
Drug Class
Central Nervous System Depression [PE]GABA A Receptor Positive Modulators [MoA]gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]
Selected Package
51991-0981-01Selected100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-981-01)